BJP veteran Laxmi Kanta Chawla hits out at Modi for apathy towards common man

Agencies
December 27, 2018

New Delhi, Dec 27: Former Punjab Minister and BJP leader Laxmi Kanta Chawla has rapped Prime Minister Narendra Modi and Railway Minister Piyush Goyal for the alleged apathy towards the common man and urged them to forget about the “bullet” train.

In a video that went viral on Wednesday, Ms. Chawla is seen aboard a train, appealing to the Modi government to “have mercy on the common man”. “I am on board the Saryu Yamuna Express for 24 plus eight hours. This train is running nine hours behind schedule. For God’s sake, forget about bullet train, focus on the trains that are already running,” she said in the video.

“Modiji, the public is distressed. Whose achche din [good times] have come, we don’t know. But most certainly, achche din have not come for the common man, for the poor and the unemployed. I have myself seen engineering diploma holder youth doing menial jobs. What have you given them?” she said.

Tells Minister to travel sometimes like a commoner

She also took on Mr. Goyal, saying the claims that milk is arranged for babies and doctors attend to the sick travelling on trains if they just tweet their needs seemed to be merely a “publicity stunt”.

 “We have been dialling railway helplines 138 and 139 and sending you [Mr. Goyal] emails but there is no one out there to listen to our woes. There is no food on this train, the seats are broken, toilet seats are dirty and doors have to be opened with a lot of difficulty,” she said.

She asked the Railway Minister to travel sometimes like a commoner in a train to see the hardships the traveller faces.

“What if Shatabdi and Rajdhani trains are good? These are for rich people. What about trains like this one in which the labourers, farmers, soldiers and their families travel? Hundreds are sleeping in the open at railway stations in this bitter cold for want of waiting rooms,” she said.

“Andher nagri, chopat raja [Dark is the nation, insane is the king],” she added.

Comments

Mohammed SS
 - 
Thursday, 27 Dec 2018

Waaaaaw... some body open the truth of real face of BJP

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 14,2020

May 14: Customs officials on Wednesday intercepted China-bound consignments of raw material for masks, misdeclared as packing materials for pouches, in large quantities, a senior official said.

It has also seized multiple shipments containing 5.08 lakh masks, 57 litres of sanitiser and 952 PPE kits bound for the US, the UK and the UAE, the official said.

The export of such goods is prohibited by the government in the wake of the COVID-19 pandemic.

"On the basis of specific intelligence, 2,480 kg of raw material for masks was intercepted by air cargo export, Delhi Customs. The goods were misdeclared as packing materials for pouches and were being illegally attempted to be smuggled/ exported to China," he said. 

These goods are prohibited for export as per the latest guidelines issued by the Directorate General of Foreign trade (DGFT), he said, adding that investigation into the case is under progress.

In another catch, the air cargo officers intercepted multiple shipments containing 5.08 lakh masks, 57 litres of sanitiser in 950 bottles and 952 PPE kits at the courier terminal in New Delhi. These were attempted to be smuggled or exported out of the country, the official said.

"These goods are also prohibited for export," he added. 

These items were being illegally exported to the United States, United Kingdom and the United Arab Emirates. "No arrests have been made so far," the official said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 18,2020

New Delhi, Jun 18: Prime Minister Narendra Modi on Thursday said he is "deeply grateful" for the overwhelming support shown by the global community for India''s membership of the UN Security Council.

India will work with all member countries to promote global peace, security, resilience and equity, he said.

India garnered 184 votes out of the 192 ballots cast in the General Assembly to win the election for the non-permanent seat in the powerful Security Council.

India''s two year term will begin on January 1, 2021.

This is the eighth time that India will sit at the UN high-table, which comprises five permanent members and 10 non-permanent members.

"Deeply grateful for the overwhelming support shown by the global community for India''s membership of the UN Security Council," the prime minister wrote on Twitter.

India will work with all member countries to promote global peace, security, resilience and equity, he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.